Standard BioTools Inc. (LAB)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 3
in 54 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About Standard BioTools Inc.
Standard BioTools Inc. develops life-science tools for healthcare and research markets, selling on NASDAQ as LAB. The company operates in medical technologies used by clinical, diagnostic, and research customers, and generated $85.3 million of revenue in FY2025. Its portfolio spans instrumentation, consumables, services, and assays, including the Hyperion spatial biology platform.
Today's Snapshot
LAB opened 1.9% lower at 0.71, while its sector was flat.
Trading Volume
Below 10d avg (1.8M)
100.7K
vs S&P 500 Today
Strong Underperformance
-4.38%
Updated: September 10, 2026 at 14:50 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$0.69 - $1.01Sell
- RSI (14)45.65Neutral
- Stochastic %K (14, 3, 3)72.27Neutral
- MACD Level (12, 26)-0.02Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.